Amedisys (NASDAQ:AMED) edged lower by 1.2% after a judge tentatively set a date for the Dep. of Justice's challenge of ...

Amid the U.S. Department of Justice’s (DOJ) legal battle with UnitedHealth Group (NYSE: UHG) regarding the planned purchase of Amedisys (Nasdaq: AMED), ...

The probe is analyzing the company’s practice of frequently logging diagnoses that trigger larger payments to its Medicare ...

Empowered Funds LLC bought a new stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) during the fourth quarter, Holdings ...

Shares tumbled after The Wall Street Journal reported that the insurer is under Justice Department investigation.

A trial between the Justice Department and UnitedHealth Group Inc. over its proposed purchase of Amedisys Inc. will take place in October 2025, a Maryland federal judge ruled Thursday.

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...

UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...

Shares of the company fell nearly 10% in premarket trading. Shares of other health insurers also fell before the bell. The ...

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.